A clinical study of anti-aging effect for test product
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000048899
- Lead Sponsor
- DHC Corporation Primary Research Unit Primary Research Group 1
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 22
Not provided
participants who are pregnant, in nursing condition, or planning to become pregnant; participants who are treated with immune-suppressant within one month from the conduct of the study; participants who participated in a previous study without an appropriate intervening period of one month between studies; participants who have sensitive or hypersensitive skin; participants who have damaged skin in or around the test site, which includes sunburn, tattoos, scars, or other disfiguration on the test site; participants who used similar treatment related to the study during the previous three months; participants who had an experience on test site (skin microdermabrasion, Botox and other skin treatment); participants who have chronic disease (diabetes, asthma, or high blood-pressure); participants who have atopic dermatitis; and participants who have any problem, which might interfere with the healing process.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method kin anti-aging parameters, such as skin hydration, elasticity, lightness, dermal density, sagging, wrinkle and eyebag, are evaluated at baseline, 4 weeks and 8 weeks after treatment.
- Secondary Outcome Measures
Name Time Method Assessment of self-questionnaires